ULM receives research grant for promising treatment of psoriasis

Local News

MONROE, La. (Press Release) – The Office of Sponsored Programs and Research announces the University of Louisiana Monroe has received a grant award of $84,600 from the Louisiana Biomedical Research Network.

The funding is for the “The Role of mTOR and its targeting by fisetin for treating psoriasis” project written by Jean Chamcheu, Ph.D., an assistant professor in the College of Pharmacy.

Chamcheu’s research grant focuses on using natural products to treat chronic, inflammatory skin diseases with an emphasis on psoriasis. Psoriasis is a common chronic and currently incurable inflammatory skin disease that affects an estimated 2-3 percent of the world’s population, including more than eight million individuals in the United States.

“I’m very excited with this grant award because its funding will ensure collaborative ties between ULM and LSU. It will also promote the development of a cost-effective and natural therapy. If the outcome of our studies can direct us toward developing a therapeutic strategy to treat skin inflammation and psoriasis symptoms, it will have a major impact on the quality of life for many Americans and people around the world,” Chamcheu said.

This grant award can, in part, be attributed to the successes and profound research teams from the College of Pharmacy, including Khalid El Sayed, Ph.D.Yong-Yu Liu, M.D., Ph.D.Seetharama Jois, Ph.D., and Karen Briski, Ph.D., and Dr. Sonika Patial from LSU School of Veterinary Medicine.

“This project is a great example of the collaborative efforts of ULM faculty to meet health needs by helping to produce affordable and natural solutions to diseases. Our faculty are dedicated to their students and to making important strides in their fields of study,” said Meghan Risinger, Grants/Projects Developer in OSPR.

Stay up to date with the latest news by downloading the KTVE/KARD News App from the App Store or Google Play.

Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Don't Miss

Don't Miss

Trending Stories